Integer (ITGR) Projected to Post Quarterly Earnings on Thursday

Integer (NYSE:ITGR) is expected to be announcing its earnings results before the market opens on Thursday, February 20th. Analysts expect the company to announce earnings of $1.46 per share and revenue of $446.28 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Integer Stock Performance

Shares of NYSE:ITGR opened at $140.95 on Wednesday. The company has a market cap of $4.73 billion, a price-to-earnings ratio of 43.50, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13. The company has a 50-day moving average price of $137.90 and a 200-day moving average price of $132.00. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. Integer has a 12 month low of $97.49 and a 12 month high of $146.36.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on ITGR shares. KeyCorp upped their price objective on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Truist Financial boosted their price target on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Finally, Piper Sandler reiterated an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, Integer has a consensus rating of “Moderate Buy” and an average price target of $146.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.